Rationale and design of a randomized study to assess the efficacy and safety of evolocumab in patients with diabetes and dyslipidemia: the BERSON clinical trial
Clinical Cardiology,Volume 0, Issue ja, -Not available-.
Source: Clinical Cardiology - Category: Cardiology Authors: Alberto J.
Lorenzatti
MD
,
Freddy G.
Eliaschewitz
MD
,
Yundai
Chen
MD
,
Jonathan
Fialkow
MD
,
Juming
Lu
MD
,
Alexis
Baass
MD
,
Maria Laura
Monsalvo
MD
,
Hui ‐Chun
Hsu
ScM
,
Ransi
Somaratne
MD
,
Junbo
Ge
MD Source Type: research